Acute Anterior Uveitis Following Intravitreal Injection of Bevacizumab
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVE: To report five cases of iritis after intravitreal injection of bevacizumab. PATIENTS AND METHODS: The clinical charts of patients who received intravitreal injections of bevacizumab or ranibizumab from January 2009 to September 2011 by one physician were retrospectively reviewed. RESULTS: A total of 1,097 injections of bevacizumab and 571 of ranibizumab were administered. Five patients developed acute anterior uveitis and presented with severe pain, photophobia, conjunctival injection, and anterior chamber reaction 2 to 24 hours after intravitreal injection of bevacizumab. All five patients were treated with topical corticosteroids with rapid resolution of the inflammation. CONCLUSION: Although uncommon, acute iritis is a complication of intravitreal injection of bevacizumab.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Less commonly, corneal edema, conjunctival injection, ocular pain, photophobia, hypopyon, keratic precipitates, trabeculitis, retinal infiltrates and hemorrhages may occur [2, 11, 12, 14, 16–19].”
From Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review (2021) · cites this paper as [18]
Citations
Cites
(2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.03.057 · Cited by 4,396
Ranibizumab and bevacizumab for neovascular age-related macular degeneration
(2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102673 · Cited by 2,669
Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration
Avery, R. L., Pieramici, D. J., Rabena, M. D., Castellarin, A. A., Nasir, M. A., & Giust, M. J. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.11.019 · Cited by 1,133
Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy
Avery, R. L., Pearlman, J., Pieramici, D. J., Rabena, M. D., Castellarin, A. A., Nasir, M. A., Giust, M. J., Wendel, R., & Patel, A. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.05.064 · Cited by 799
Pharmacokinetics of Intravitreal Bevacizumab (Avastin)
Bakri, S. J., Snyder, M. R., Reid, J. M., Pulido, J. S., & Singh, R. J. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.01.017 · Cited by 683
SPAIDE, R. F., LAUD, K., FINE, H. F., KLANCNIK, J. M., MEYERLE, C. B., YANNUZZI, L. A., SORENSON, J., SLAKTER, J., FISHER, Y. L., & COONEY, M. J. (2006) · Retina · doi:10.1097/00006982-200604000-00001 · Cited by 630
ITURRALDE, D., SPAIDE, R. F., MEYERLE, C. B., KLANCNIK, J. M., YANNUZZI, L. A., FISHER, Y. L., SORENSON, J., SLAKTER, J. S., FREUND, K. B., COONEY, M., et al. (2006) · Retina · doi:10.1097/00006982-200603000-00005 · Cited by 460
Toxic anterior segment syndrome
Mamalis, N., Edelhauser, H. F., Dawson, D. G., Chew, J., LeBoyer, R. M., & Werner, L. (2006) · Journal of Cataract and Refractive Surgery · doi:10.1016/j.jcrs.2006.01.065 · Cited by 311
RABENA, M. D., PIERAMICI, D. J., CASTELLARIN, A. A., NASIR, M. A., & AVERY, R. L. (2007) · Retina · doi:10.1097/iae.0b013e318030e77e · Cited by 245
INCIDENCE OF ENDOPHTHALMITIS RELATED TO INTRAVITREAL INJECTION OF BEVACIZUMAB AND RANIBIZUMAB
FINTAK, D. R., SHAH, G. K., BLINDER, K. J., REGILLO, C. D., POLLACK, J., HEIER, J. S., HOLLANDS, H., & SHARMA, S. (2008) · Retina · doi:10.1097/iae.0b013e3181884fd2 · Cited by 214
Cited by
Anderson, W. J., da Cruz, N. F. S., Lima, L. H., Emerson, G. G., Rodrigues, E. B., & Melo, G. B. (2021) · International Journal of Retina and Vitreous · doi:10.1186/s40942-021-00307-7 · Cited by 155
Vitreous Inflammation Associated with Intravitreal Anti-VEGF Pharmacotherapy
Agrawal, S., Joshi, M., & Christoforidis, J. B. (2013) · Mediators of Inflammation · doi:10.1155/2013/943409 · Cited by 83
“Time to resolution 2–12 weeks [11, 15, 17, 18, 20, 24] Extremely variable”
BackgroundKim, S.-H., Kang‐Mieler, J. J., Liu, W., Wang, Z., Yiu, G. C., Teixeira, L. B. C., Mieler, W. F., & Thomasy, S. M. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.3.30 · Cited by 39
“32,41 In the present study, a nondegradable aflibercept DDS was used to facilitate identification of the material with histopathology.”
Protective effect of a Chinese Medicine formula He-Ying-Qing-Re Formula on diabetic retinopathy
Wang, L., Wang, N., Tan, H., Zhang, Y., & Feng, Y. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.04.031 · Cited by 40
“, 2014) and uveitis (Mozayan and Farah, 2013) compared to untreated group.”
BackgroundReddy, A. K., Cabrera, M., Yeh, S., Davis, J. L., & Albini, T. A. (2014) · Retina · doi:10.1097/iae.0000000000000274 · Cited by 21
“Anterior uveitis is a rare complication that has been described after bevacizumab and ranibizumab.(30,31) It is not clear whether this risk is increased in patients with history of uveitis, although Okada et al(32) have reported a case of pan uveitis recurrence after bevacizumab.”
Background
Metadata
- Authors
- Mozayan, A., & Farah, S.
- Affiliations
- Albert Einstein College of Medicine (US)
- Venue
- Ophthalmic Surgery, Lasers and Imaging Retina
- Publisher
- SLACK, Inc.
- Published
- 2013-01
- Volume
- 44
- Issue
- 1
- Pages
- 25-27
- ISSN
- 1542-8877 (ISSN-L)
- 2325-8160
- 2325-8179
- OpenAlex
- W1979581633
- Cited by
- 22
- References
- 18
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 4 · 2018: 1 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 4
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Ophthalmic surgery, lasers & imaging retina (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- acute anterior uveitis, iritis, bevacizumab, intravitreal injection, ranibizumab, adverse drug reactions, injection complications, topical corticosteroids, anti-VEGF therapy
- MeSH terms
- Bevacizumab, Ranibizumab, Acute Disease, Aged, Aged, 80 and over, Conjunctivitis, Female, Glucocorticoids, Humans, Iritis, Retinal Diseases, Retrospective Studies, Visual Acuity, Incidence, Angiogenesis Inhibitors, Photophobia, Vascular Endothelial Growth Factor A, Eye Pain, Intravitreal Injections, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acute Anterior Uveitis Following Intravitreal Injection of Bevacizumab. https://app.cochat.ai/papers/10.3928/23258160-20121221-08
- The paper
- Mozayan, A., & Farah, S. (2013). Acute Anterior Uveitis Following Intravitreal Injection of Bevacizumab. Ophthalmic Surgery, Lasers and Imaging Retina. https://doi.org/10.3928/23258160-20121221-08
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.